Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C

Journal of Urology

Volumn 156, Issue 4, 1996, Pages 1492-1495

  Okamoto, E ^a   Kinne, R K H ^a   Sokeland J ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

bladder neoplasms; bromodeoxyuridine; doxorubicin; interferons; mitomycin C

Indexed keywords

ALPHA INTERFERON; BROXURIDINE; DOXORUBICIN; GAMMA INTERFERON; MITOMYCIN C;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTRAVESICAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0029818835     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65637-4     Document Type: Article

References (17)

1. Herr, H. W., Laudone, V. P. and Whitmore, W. F., Jr.: An overview of intravesical therapy for superficial bladder tumors. J. Urol., 138: 1363, 1987.
2. Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D. and Hawkins, I. R.: Superficial bladder cancer: progression and recurrence. J. Urol., 130: 1083, 1983.
3. Jones, H. C. and Swinney, J.: Thiotepa in treatment of tumors of the bladder. Lancet, ii: 615, 1961.
4. Chai, M., Wientjes, M. G., Badalament, R. A., Burgers, J. K. and Au, J. L.-S.: Pharmacokinetics of intravesical doxorubicin in superficial bladder cancer patients. J. Urol., 152: 374, 1994.
5. Pestka, S., Langer, J. A., Zoon, K. C. and Samuel, C. E.: Interferons and their actions. Annu. Rev. Biochem., 56: 727, 1987.
6. Herberman, R. R., Ortaldo, J. R. and Bonnard, G. D.: Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature, 277: 221, 1979.
7. Borden, E. C., Groveman, D. S., Nasu, T., Reznikoff, C. and Bryan, G. T.: Antiproliferative activities of interferons against human bladder carcinoma cell lines in vitro. J. Urol., 132: 800, 1984.
8. Groveman, D. S., Borden, E. C., Merritt, J. A., Robins, H. I., Steeves, R. and Bryan, G. T.: Augmented antiproliferative effects of interferons at elevated temperatures against human bladder carcinoma cell lines. Cancer Res., 44: 5517, 1984.
9. Glashan, R. W.: A randomized controlled study of intravesical α-2b-interferon in carcinoma in situ of the bladder. J. Urol., 144: 658, 1990.
10. Quastler, H. and Sherman, F. G.: Cell population kinetics in the intestinal epithelium of the mouse. Exp. Cell Res., 17: 420, 1959.
11. Gratzner, H. G., Leif, R. C., Ingram, D. J. and Castro, A.: The use of antibody specific for bromodeoxyuridine for the immunofluorescent determination of DNA replication in single cells and chromosomes. Exp. Cell Res., 95: 88, 1975.
12. Gratzner, H. G., Pollack, A., Ingram, D. J. and Leif, R. C.: Deoxyribonucleic acid replication in single cells and chromosomes by immunologic techniques. J. Histochem. Cytochem., 24: 34, 1976.
13. Gonchoroff, N. J., Katzmann, J. A., Currie, R. M., Evans, E. L., Houck, D. W., Kline, B. C., Greipp, P. R. and Loken, M. R.: S-phase detection with an antibody to bromodeoxyuridine. J. Immunol. Methods, 93: 97, 1986.
14. Gratzner, H. G.: Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science, 218: 474, 1982.
15. Walker, M. C., Parris, C. N. and Masters, J. R.: Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs. J. Natl. Cancer Inst., 79: 213, 1987.
16. Schmittgen, T. D., Au, J. L.-S., Wientjes, M. G., Badalament, R. A. and Drago, J. R.: Cultured human bladder tumors for pharmacodynamic studies. J. Urol., 145: 203, 1991.
17. Schmittgen, T. D., Wientjes, M. G., Badalament, R. A. and Au, J. L.-S.: Pharmacodynamics of mitomycin C in cultured human bladder tumors. Cancer Res., 51: 3849, 1991.